Welcome to Trylle Biologics

We are merging biology and digital technology with innovative use of engineered human collagen in AI-driven medical devices and new neural interfaces.

At Trylle Biologics, we are dedicated to advancing healthcare through the integration of innovative biocompatible materials and cutting-edge digital technology. Our pioneering work focuses on developing medical devices and solutions using human-derived collagen, engineered from fibroblast cells in scalable bioreactors. This core technology serves as the foundation for our diverse product portfolio, driving new standards in personalized care and secure data management.

Our Technology

Human Collagen Manufacturing

Our proprietary platform produces high-purity, biocompatible human collagen, a critical component in all our medical devices. By utilizing engineered fibroblast cells, we generate extracellular matrix (ECM) proteins that enhance the functionality and compatibility of our products. This advanced technology allows us to create versatile medical solutions that address a wide range of healthcare needs.

Innovative Products

CareWidget

CareWidget is our flagship product, revolutionizing patient care and secure identification. By integrating human collagen with AI-powered check-in agents, CareWidget offers personalized, real-time healthcare solutions. This device seamlessly interfaces with existing Electronic Health Record (EHR) systems, improving workflow efficiency and enhancing patient outcomes.

RevolutionCheck

RevolutionCheck is a comprehensive SaaS platform designed for secure identification and data management. Paired with CareWidget, it offers a robust solution for healthcare providers, financial institutions, and military applications. Leveraging AI and blockchain technology, RevolutionCheck ensures the safe storage and transmission of sensitive information, setting new benchmarks in data security.

Brain-Machine Interface (BMI)

Our cutting-edge Brain-Machine Interface (BMI) technology represents the next frontier in medical innovation. Utilizing our human collagen platform, this device enhances neural interfaces, enabling groundbreaking applications in neurology and prosthetics. Our BMI technology aims to improve tissue integration, reduce immune response, and offer long-lasting solutions for patients with complex medical needs.

Join Us in Revolutionizing Healthcare

At Trylle Biologics, we are not just creating products; we are shaping the future of healthcare. Our commitment to innovation, quality, and patient care drives everything we do. Whether you are a healthcare provider, investor, or partner, we invite you to join us on this exciting journey toward a healthier, more connected world.

For more information about our products, services, or investment opportunities, please reach out to us at info@trylleinc.com.